AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Breakthrough in RRP Treatment: A Landmark Achievement
This chapter highlights a significant advancement in the treatment of recurrent respiratory papillomatosis, including the recent breakthrough designation and the upcoming submission of a rolling Biologics License Application. The discussion emphasizes the excitement around trial results and sets the stage for future commercialization plans in 2025.